Memory supplements: what the trials found for the whole shelf
Across ginkgo, omega-3 and B vitamins, the trials in healthy and mildly forgetful older adults mostly land on no difference, with a few narrow exceptions that do not extend to the whole shelf.

Walk the memory aisle and most of the shelf does not beat a sugar pill. Ginkgo, fish oil and B vitamins have each been tested in older adults. The honest summary is mostly nothing, with a few narrow wins tied to a specific dose, a specific group, or a specific length of time.1,2
Ginkgo depends entirely on who takes it
Ginkgo biloba is the most heavily tested memory herb. The newest, largest review split its results by diagnosis instead of pooling everyone together. In people with mild cognitive impairment, twelve trials covering more than 1,900 participants found ginkgo probably makes little to no difference to global cognitive status after six months.1 That is the group closest to ordinary shoppers: not diagnosed with dementia, just more forgetful than before.
The same review found something different in people who already had dementia. There, ginkgo showed small to moderate benefits on cognition and daily functioning, though the review rated that evidence low-certainty.1 That split matters. Helping once memory loss has become dementia is not the same as preventing or delaying it, and the trials in the healthy-to-mildly-forgetful range did not show an effect.
Dose and duration explain some of the scatter in earlier, smaller reviews. An overview of systematic reviews of ginkgo in dementia concluded that doses under 200 milligrams a day were not enough to produce a measurable effect.5 Benefit showed up at higher doses, taken for 22 weeks or more. A bottle supplying less than that, for a few weeks, is not testing what those trials tested.
B vitamins move a blood marker more reliably than they move memory
B vitamins lower homocysteine, a blood substance linked to higher dementia risk. The logic is simple: lower the marker, protect the memory. The trials complicate that story.
A large meta-analysis pooling randomized trials and cohort studies found a small overall benefit on a standard cognitive test, the Mini-Mental State Examination. In people without dementia the gain was 0.15 points (range 0.04 to 0.25), concentrated in trials running more than a year.2 Once dementia was already present, the same review found no benefit: 0.20 points, with a range from -0.35 to 0.75.2 That is a narrow window: years of supplementation, before symptoms progress, in people not yet impaired.
The clearest test of whether lowering the marker moves memory comes from a large trial in people who had already had a stroke or a related warning event. Over nearly three years, B vitamins reliably lowered homocysteine.3 Test scores in the two groups barely moved: the gap was 0.03 points, with a range from -0.13 to 0.19.3
A separate small meta-analysis in people with Alzheimer's disease or dementia found the same pattern: homocysteine dropped, but the standard memory test did not budge.6 Lowering the marker and preserving memory are not the same finding.
Omega-3 has one specific, narrow win
Fish oil's memory evidence looks different, because it is not really about dementia risk. A review looked at memory tasks in healthy adults, not diagnosed cognitive decline. It found that omega-3 intake above one gram a day of combined DHA and EPA improved episodic memory, the kind used to recall a specific event.4 That effect held regardless of how sharp or foggy people's memory was to start.
The catch is in what the evidence did not test. This was a review of memory performance in generally healthy adults, not a dementia-prevention trial. The benefit was specific to episodic memory, not every kind of recall. It says something real about a gram-plus of combined DHA and EPA on one narrow memory task. It does not automatically extend to preventing decline over years.
Where the shelf overpromises
Put the three together and a pattern appears. Every supplement here has at least one trial or review behind it, which is what lets a product claim to be "backed by research." What that claim skips is which population, which dose, and which outcome the research actually covered.
Ginkgo showed small, low-certainty benefits in dementia and probably none in ordinary forgetfulness.1 B vitamins showed a small benefit before dementia set in, over more than a year, and none once it had.2 Omega-3's win is a memory task in healthy adults, not a slowed rate of decline.4 None of these is the same claim as "improves your memory." None of the reviews found benefits that were large, fast or universal.
A front label rarely says any of this. It lists an ingredient and a total dose, not the population the trials tested or the number of weeks a benefit took to show up. A shopper comparing two ginkgo bottles on price alone has no way to tell which one supplies the 200 milligrams a day the dementia trials tied to a measurable effect, and which one falls short of it. The gap between what a label can say and what a trial actually found is where most of the overpromising happens, not in any single fabricated claim.
What remains unknown
None of these reviews followed people for more than a few years. Nothing here says what happens after a decade of daily supplementation, the timescale that actually determines whether someone develops dementia. The homocysteine trials leave a real question open: why lowering the marker so reliably fails to move memory scores is still not settled. That gap applies to any supplement sold on the strength of a blood marker rather than a memory test. Dose comparisons are thin across the board. The 200 milligram line for ginkgo comes from an overview of reviews rather than from trials that compared doses head to head, so "how much" remains a guess built from a handful of studies. What the evidence supports is narrower than the marketing implies: real effects, in specific people, at specific doses, for specific outcomes, not the general promise on the label.
QUESTIONS THIS POST ANSWERS
- Does ginkgo work for memory?
- It depends who is taking it. In people with ordinary age-related forgetfulness or mild cognitive impairment, the largest review found ginkgo probably makes little to no difference to cognition or daily function. In people already diagnosed with dementia, the same review found small to moderate benefits on cognition and daily living scores, and an earlier analysis tied that benefit to a dose of at least 200 milligrams a day taken for 22 weeks or longer.
- Do B vitamins slow memory loss?
- The overall trial evidence leans toward a small benefit, mainly in people without dementia and in trials that ran longer than a year, with almost no benefit once dementia was already present. One large trial in people who had already had a stroke found B vitamins lowered a blood marker linked to memory risk but left memory scores unchanged after nearly three years.
REFERENCES
Each reference was re-checked against PubMed before publication. How sources are checked
- 1Wieland LS, et al. Ginkgo biloba for cognitive impairment and dementia. The Cochrane database of systematic reviews. 2026. Source
- 2Wang Z, et al. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis. Nutrition reviews. 2022. Source
- 3Hankey GJ, et al. Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis. Stroke. 2013. Source
- 4Yurko-Mauro K, et al. Docosahexaenoic acid and adult memory: a systematic review and meta-analysis. PloS one. 2015. Source
- 5Yuan Q, et al. Effects of Ginkgo biloba on dementia: An overview of systematic reviews. Journal of ethnopharmacology. 2017. Source
- 6Zhang DM, et al. Efficacy of Vitamin B Supplementation on Cognition in Elderly Patients With Cognitive-Related Diseases. Journal of geriatric psychiatry and neurology. 2017. Source